Presentation is loading. Please wait.

Presentation is loading. Please wait.

A review of the current guidelines for allergic rhinitis and asthma

Published byBernice Hopkins Modified over 5 years ago

Similar presentations

Presentation on theme: "A review of the current guidelines for allergic rhinitis and asthma"— Presentation transcript:

1 A review of the current guidelines for allergic rhinitis and asthma
Robert F. Lemanske, MD  Journal of Allergy and Clinical Immunology  Volume 101, Issue 2, Pages S392-S396 (February 1998) DOI: /S (98) Copyright © 1998 Mosby, Inc. Terms and Conditions

2 Fig. 1 Long-term management of asthma: a stepwise approach. From Global Initiative for Asthma. National Institutes of Health; NHLBI Publication No Journal of Allergy and Clinical Immunology  , S392-S396DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

3 Fig. 2 Management of exacerbation of asthma: home treatment. Patients at high risk of asthma-related death should contact a clinician promptly after initial treatment. Additional therapy may be required. From Global Initiative for Asthma. National Institutes of Health; NHLBI Publication No Journal of Allergy and Clinical Immunology  , S392-S396DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

Download ppt "A review of the current guidelines for allergic rhinitis and asthma"

Similar presentations

Shin-Ichi Nishikawa, MD, PhD 

Shin-Ichi Nishikawa, MD, PhD 
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research.

Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research.
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Ulf Darsow, MD, Dieter Vieluf, MD, Johannes Ring, MD, PhD 

Ulf Darsow, MD, Dieter Vieluf, MD, Johannes Ring, MD, PhD 
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Rosa Codina, PhD, Richard F. Lockey, MD 

Rosa Codina, PhD, Richard F. Lockey, MD 
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Practice Notes from the AAAI

Practice Notes from the AAAI
Allergic skin diseases

Allergic skin diseases
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
NAEPP Expert Panel Report

NAEPP Expert Panel Report
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Similar presentations

Ads by Google